Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number: 000-31705

GHST World Inc.

(Exact name of registrant as specified in charter)

Delaware		91-2007477
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

667 Madison Avenue 5th Floor New York, NY		10065
(Address of principal executive offices)		(Zip Code)

+1 (212) 634-6860

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by checkmark whether the registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act..

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of May 10, 2024, the issuer had 130,201,179 shares of its common stock, $0.001 par value per share, outstanding.

TABLE OF CONTENTS

		Page
	PART I - Financial Information

Item 1	Financial Statements	1
	Consolidated Balance Sheets – As of March 31, 2024 (Unaudited) and June 30, 2023	1
	Consolidated Statements of Comprehensive Loss (Unaudited) – For the Three and Nine Months Ended March 31, 2024 and 2023	2
	Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) – For the Three and Nine Months Ended March 31, 2024 and 2023	3
	Consolidated Statements of Cash Flows (Unaudited) – For the Nine Months Ended March 31, 2024 and 2023	4
	Condensed Notes to Consolidated Financial Statements (Unaudited)	5

Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10
Item 3	Quantitative and Qualitative Disclosures About Market Risk	11
Item 4	Controls and Procedures	11

	Part II - Other Information

Item 1	Legal Proceedings	12
Item 1A	Risk Factors	12
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	12
Item 3	Defaults Upon Senior Securities	12
Item 4	Mine Safety Disclosures	12
Item 5	Other Information	12
Item 6	Exhibits	13

Signatures		14

PART I: FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

GHST World Inc.

Consolidated Balance Sheets


	March 31, 2024			June 30, 2023
	(Unaudited)
Assets

Current Assets
Cash	$	76		$	39,495
Accounts receivable		6,348			—
Total Current Assets		6,424			39,495


Total Assets	$	6,424		$	39,495

Liabilities and Stockholders’ Deficit

Current Liabilities
Accounts payable and accrued expenses	$	26,339		$	1,112
Advances from related parties		214,863			126,496
Common stock payable		9,559			9,559
Deferred revenue		17,367			23,841
Total Current Liabilities		268,128			161,008

Commitments and Contingencies (Note 6)		—			—

Stockholders’ Deficit
Preferred stock, $0.001 par value; 10,000,000 shares authorized; Series A, 6,000 shares issued and outstanding at March 31, 2024 and June 30, 2023		6			6
Series B, 2,200 shares issued and outstanding at March 31, 2024 and June 30, 2023		2			2
Common stock, $0.001 par value, 300,000,000 shares authorized; 130,201,179 shares issued at March 31, 2024 and June 30, 2023		130,201			125,725
Additional paid-in-capital		13,443,466			13,123,419
Accumulated deficit		(13,835,379	)		(13,370,665	)
Total Stockholders’ Deficit		(261,704	)		(121,513	)

Total Liabilities and Stockholders' Deficit	$	6,424		$	39,495

The accompanying notes are an integral part of these consolidated financial statements.

GHST World Inc.

Consolidated Statements of Operations

(Unaudited)


	For the Three Months Ended March 31,						For the Nine Months Ended March 31,
	2024			2023			2024			2023
				(As Restated)						(As Restated)

Revenues	$	431		$	—		$	40,126		$	—

Operating expenses:
General and administrative expenses		28,604			20,998			180,241			89,268
Product development costs		—			—			324,523			4,178
Total operating expenses		28,604			20,998			504,764			93,446

Other Income(expense):
Other income		258			—			(75	)		—
Total Other Income (expense)		258			—			(75	)		—

Net loss	$	(27,915	)	$	(20,998	)	$	(464,714	)	$	(93,446	)


Net loss per common share - basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average number of common shares outstanding - basic and diluted		130,201,179			25,239,107			128,671,141			124,967,075

The accompanying notes are an integral part of these consolidated financial statements.

GHST World Inc.

Consolidated Statements of Changes in Stockholders' Deficit

For the Three and Nine Months Ended March 31, 2024 and 2023

(Unaudited)


	Preferred Stock Series A				Preferred Stock Series B				Common Stock				Additional Paid in		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Deficit

Balance December 31, 2022		6,000	$	6		2,200	$	2		125,222,070	$	125,222	$	13,100,789	$	(13,326,539	)	$	(100,520	)
Issuance of common stock for cash		—		—		—		—		33,333		33		1,967		—			2,000
Net loss for the three months ended March 31,2023		—		—		—		—		—		—		—		(20,998	)		(20,998	)
Balance March 31, 2023 - As Restated		6,000		6		2,200		2		125,255,403		125,255		13,102,756		(13,347,537	)		(119,518	)

Balance June 30, 2022		6,000	$	6		2,200	$	2		124,430,534	$	124,431	$	13,028,646	$	(13,254,091	)	$	(101,006	)
Issuance of common stock for cash		—		—		—		—		824,869		824		74,110		—			74,934
Net loss for the nine months ended March 31, 2023		—		—		—		—		—		—		—		(93,446	)		(93,446	)
Balance March 31, 2023 - As Restated		6,000		6		2,200		2		125,255,403		125,255		13,102,756		(13,347,537	)		(119,518	)


	Preferred Stock Series A				Preferred Stock Series B				Common Stock				Additional Paid in		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance December 31, 2023		6,000	$	6		2,200	$	2		130,201,179	$	130,201	$	13,443,466	$	(13,807,464	)	$	(233,789	)
Net loss for the three months ended March 31, 2024		—		—		—		—		—		—		—		(27,915	)		(27,915	)
Balance March 31, 2023		6,000		6		2,200		2		130,201,179		130,201		13,443,466		(13,835,379	)		(261,704	)

Balance June 30, 2023		6,000		6		2,200		2		125,725,003		125,725		13,123,419		(13,370,665	)		(121,513	)
Issuance of common stock for services		—		—		—		—		4,476,176		4,476		320,047		—			324,523
Net loss for the nine months ended March 31, 2024		—		—		—		—		—		—		—		(464,714	)		(464,714	)
Balance March 31, 2024		6,000		6		2,200		2		130,201,179		130,201		13,443,466		(13,835,379	)		(261,704	)

The accompanying notes are an integral part of these consolidated financial statements.

GHST World Inc.

Consolidated Statements of Cash Flows

(Unaudited)


	For the Nine Months Ended March 31,
	2024			2023
				(As Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(464,714	)	$	(93,446	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock compensation		324,523			—
Changes in operating assets and liabilities:
Accounts receivable		(6,348	)		—
Accounts payable and accrued expenses		25,227			1,108
Deferred revenue		(6,474	)		—
Net Cash Used In Operating Activities		(127,786	)		(92,339	)

CASH FLOWS FROM FINANCING ACTIVITIES
Advances from related parties		88,367			17,737
Issuance of common stock for cash		—			74,935
Net Cash Provided By Financing Activities		88,367			92,672

Net increase (decrease) in cash		(39,419	)		332

Cash - beginning of period		39,495			206

Cash - end of period	$	76		$	538

SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the year/period for:
Interest	$	—		$	—
Taxes	$	—		$	—

The accompanying notes are an integral part of these consolidated financial statements.

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2024 and June 30, 2023

(Unaudited)

NOTE 1- ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Background

GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999. The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.

Basis of Presentation

The interim unaudited financial statements included herein have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission. In management's opinion, all adjustments (consisting of normal recurring adjustments and reclassifications) necessary to present fairly our results of operations and cash flows for the nine months ended March 31, 2024 and 2023, and our financial position as of March 31, 2024, have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.

Certain information and disclosures normally included in the notes to the annual financial statements have been condensed or omitted from these interim financial statements. Accordingly, these interim unaudited financial statements should be read in conjunction with the financial statements and notes thereto for the year ended June 30, 2023.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Liquidity and Going Concern

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had net losses of $464,714 and $93,446 for the nine months ended March 31, 2024 and 2023. The Company has an accumulated deficit of $13,835,379 and $13,370,665 as of March 31, 2024 and June 30, 2023, respectively and a stockholders’ deficit of $261,704 and $121,513 as of March 31, 2024 and June 30, 2023. The Company used $127,786 and $92,339 in cash flow from operating activities for the nine months ended March 31, 2024 and 2023.

Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next 12 months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon

profitable future operations, positive cash flows, and additional financing. These financial statements do not include any adjustments related to the recovery and classification of recorded asset amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Management intends to raise money through outside investors and related party advances as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders, officers and directors and from the possible sale of securities to other investors. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.

Principles of Consolidation

The consolidated financial statements include the accounts of the following wholly owned subsidiaries:

GHST Art World, Inc

GHST Sport Inc.

IoTT world Inc.

Insside World Inc.

All intercompany balances and transactions have been eliminated in consolidation.

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2024 and June 30, 2023

(Unaudited)

Concentration

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.

The Company currently receives all its revenues from one customer and all the deferred revenues from a few other customers. The company is dependent on its chairman of the Board of Directors for short term funding, who has provided a significant portion of the funding through March 31, 2024.

Foreign Currency

Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transactions as certain vendor payments and repayments of related party advances are done in foreign currency.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Such estimates and assumptions impact, among others, the following: fair value of share-based payments and deferred taxes.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

Cash

Cash are amounts held at local banks. The Company had no cash equivalents at March 31, 2024 or June 30, 2023.

Risks and Uncertainties

The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The Company recognizes revenue for its services for contracts with customers at a point in time when the services are completed. Payments received from customers in advance of when services are completed are reflected as deferred revenue on the accompanying consolidated balance sheets.

Accounts Receivable

Accounts receivables are recorded at the invoiced amount. The Company regularly reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. As of March 31, 2024 and June 30, 2023, the Company did not record any such allowance.

Fair Value

The carrying value of cash, other assets, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by United States generally accepted accounting principles (GAAP) consists of three levels:

Level one — Quoted market prices in active markets for identical assets or liabilities.

Level two — Inputs other than level one inputs that are either directly or indirectly observable; and

Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2024 and June 30, 2023

(Unaudited)

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has no assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the nine months ended March 31, 2024 and June 30, 2023.

Impairment of Long-Lived Assets

The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets for the Company consist primarily of other assets and patents. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset-by-asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets.

Research and Development

Research and development costs are expensed as incurred. These costs consist primarily of costs related to the development of new products.

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

Stock Based Compensation

The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. We measure stock-based compensation using the fair market value of the Company’s common stock on the date of the grant.

Net Loss Per Share

Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. The Company had no potentially dilutive securities outstanding for the nine months ended March 31, 2024 or 2023.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires measurement and recognition of expected credit losses for financial assets. ASU 2016-13 also requires new disclosures for financial assets measured at amortized cost, loans, and available-for-sale debt securities. ASU 2016-13 is effective for the Company beginning July 1, 2023. Adopting the standard did not have a material impact on the unaudited consolidated financial statements.

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2024 and June 30, 2023

(Unaudited)

NOTE 3- PATENTS

The Company obtained a US patent dated June 30, 2020, which is a protection device used in sporting activity with monitoring capabilities. The Company has also obtained a European Patent for the same device in October 2022. The Company has accumulated costs of $39,181 through June 30, 2022, to register the patents and had additional costs of $4,578 for the year ended June 30, 2023. The Company executed a joint venture agreement to monetize the patents, however as the Company has not generated any revenues to date from the use of the patents and thus, the Company has recorded an impairment totaling $39,181 as of June 30, 2022. Any future costs will be expensed as incurred as patent development expense until any capitalization is deemed appropriate. The Company had no patents and patents development costs during the nine month ended March 31, 2024.

NOTE 4- COMMON STOCK PAYABLE

The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion was contingent on the Company effectuating a 1-for-100 reverse stock split which was effected on September 30, 2021. As of March 31, 2024, and June 30, 2023, the Company has a total of $9,559 that has not been converted to common stock.

NOTE 5- RELATED PARTY TRANSACTIONS

At March 31, 2024 and June 30, 2023, the Company owed related parties a total of $214,863 and $126,496, respectively. These shareholder loans are unsecured, non-interest bearing and are due on demand.

As shown in Note 4, the Company has committed to converting certain debts to equity. Included in the debts is $9,559 as of March 31, 2024, of amounts due to related parties that will be converted as described in Note 4.

NOTE 6- STOCKHOLDERS’ EQUITY

On September 22, 2023, the Company entered into an agreement with cross-ING AG, an artificial intelligence development entity in Switzerland. The joint venture was formed to create and deliver the software package tailored for GHST Sport Inc. The start of the project was October 2, 2023, with the initial payment due upon each milestone’s endorsement by the Steering Group, totaling 40,000 CHF (approximately 45,272 USD). In connection with the agreement the Company issued 4,476,176 shares of common stock on October 2, 2023, which the Company has agreed not to sell for a period of two years. For accounting purposes, the value of the shares on the date of issuance was $324,523 based on the closing price of the Company’s stock on September 22, 2023. Royalties will also be due under this agreement amounting to 1 CHF per unit sold up to 150,000 units.

NOTE 7- COMMITMENTS AND CONTINGENCIES

Legal Matters

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. There are no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations.

NOTE 8- IMPACT OF RESTATEMENT

The restatement and adjustments arising therefrom relates to the following corrections of errors contained in the previous financial statements for some or all of the Affected Periods: (i) the inclusion of a new non-cash expense arising from the issuance of approximately 118,663,761 shares of common stock during the fiscal year ended March 31, 2022 in satisfaction of indebtedness at an average price per share of approximately $0.00185, below the fair market value of the shares, (ii) a non-cash impairment related to the Company’s 119 art paintings, (iii) a non-cash write-off of patent costs, and (iv) a write-off of a related party receivable. As a result of these corrections, the Company’s net loss for the fiscal year ended March 31, 2022 increased from $151,885 as was reflected in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022 to approximately $3,987,000.

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2024 and June 30, 2023

(Unaudited)

See below for a reconciliation from the previously reported March 31, 2023 consolidated financial statement to the restated amounts in the consolidated statement of operations, consolidated statement of changes in stockholder’ deficit and consolidated statement of cash flows for the nine months ended March 31, 2023. The previously reported amounts were derived from the Company's Annual Report on Form 10-Q for the nine months ended March 31, 2023 as filed with the SEC on September 1, 2023 (the “Original Report”). These amounts are labeled as “As Previously Reported” in the tables below. The amounts labeled “Restatement Adjustment” represent the effects of this restatement described above. The following presents a reconciliation of the impacted consolidated financial statement line items as previously reported to the restated amounts as of March 31, 2023:


As of March 31, 2023
	As previously reported		Restatement Adjustment			As restated
Consolidated Balance Sheet
Patent costs	$	40,362	$	(40,362	)	$	—

For The Three Months Ended March 31, 2023
		As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	21,286		$	(288	)	$	20,998
Impairment of long-lived assets		—			—			—
Depreciation and Amortization		1,598			(1,598	)		—
Patent development costs		—			—			—
Net Loss	$	(22,884	)	$	(1,886	)	$	(20,998	)


For The Nine Months Ended March 31, 2023
	As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	89,449		$	(181	)	$	89,268
Impairment of long-lived assets		115,000			(115,000	)		—
Depreciation and Amortization		2,997			(2,997	)		—
Patent development costs		—			4,178			4,178
Net Loss	$	(207,446	)	$	(114,000	)	$	(93,446	)

Consolidated Statement of Changes in Stockholders’ Deficit
Accumulated deficit	$	(9,626,393	)	$	(3,721,144	)	$	(13,347,537	)
Total stockholders’ equity (deficit)	$	(64,815	)	$	(54,702	)	$	(119,518	)
Consolidated Statement of Cash Flow
Net cash used in operating activities	$	(88,339	)	$	(4,000	)	$	(92,339	)
Net cash provided by financing activities	$	92,850		$	(178	)	$	92,672
Net cash used in investing activities	$	(4,178	)	$	4,178		$	—

NOTE 9- SUBSEQUENT EVENTS

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements were issued for potential recognition or disclosure. The Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

Overview

We are a holding company for various technology and related activities. As of the date of this Quarterly Report on Form 10-Q (this “Report”), our principal business strategy is seeking to exploit a patent and obtain and exploit future patents for the Smart Shin Guard, and developing a business through a subsidiary formed in April 2023 with an initial focus on the clean energy and defense sectors.

The Smart Shin Guard is a wearable protective device used while playing soccer and other sports combined with data collection and analysis technology that monitors players’ individual and collective physical and performance-based metrics and transmits this information to a separate module in real-time.

We have not generated revenue on a consistent basis or in amounts which are necessary to offset operating losses, and need substantial additional financing to continue the development and commercialization of our business plan and related products and service.

Recent Developments

During the three months ended March 31, 2024, the Company has continued its development efforts with respect to the Smart Shin Guard, including working with its third party service provider to procure a newly developed prototype for the product for further research and development.

In addition, InSSIDEWorld as continued its efforts to procure solar panel systems, and is in the process of seeking the necessary financing for such systems, as well as evaluating prospective markets for selling these systems.

Results of Operations

The following discussion should be read in conjunction with the financial statements and notes thereto included elsewhere in this report.

Fiscal Quarter Ended March 31, 2024 Compared to the Fiscal Quarter Ended March 31, 2023

We had revenues of $431 in the three months ended March 31, 2024 and no revenue in the three months ended 2023, and we sustained net losses of $27,915 and $20,998, respectively, in those periods. During the three months ended March 31, 2024 and 2023, expenses consisted primarily of general and administrative expenses, including general business administration and professional fees for legal and financial services.

Nine Months Ended March 31, 2024 Compared to the Nine Months Ended March 31, 2023

We had revenues of $40,126 in the nine months ended March 31, 2024 and no revenue in the nine months ended 2023, and we sustained net losses of $464,714 and $93,446, respectively, in those periods. The revenue in the 2024 period resulted from the provision of consulting services through InSSiDe World.

Our total operating expenses were $504,764 and $93,446 during the nine months ended March 31, 2024 and 2023, respectively, reflecting increased product development costs of $324,523 in the 2024 period compared to $4,178 in the 2023 period, and increased general and administrative expenses of $180,241 in the 2024 period compared to $89,268 in the 2023 period. The increase in product development costs related to research and development efforts and services for our Smart Shin Guard and our ongoing efforts with respect to InSSiDe World, each of which is still in the early stages.

We do not expect to generate material revenue on a consistent basis unless and until we can implement our business plan and begin marketing and selling our products and services in sufficient quantities, which was previously delayed due to impacts of external factors and our limited capital resources on our development efforts. We may encounter further delays, and are currently in search of collaboration partners and strategic alliances and transactions to further advance our business.

We also may encounter difficulties commercializing our products and services in the future based on supply chain issues, inflation and adverse market conditions which may result, as well as other factors beyond our control. In order to become profitable, we will need to establish a sufficient market for our products and services, including internationally, to offset our development, manufacturing and advertising costs, and our ability to do so will be subject to a number of factors, many of which will be beyond our control.

Liquidity and Capital Resources

Net Cash used by Operating Activities:

For the nine months ended March 31, 2024, net cash used in operating activities was $(127,786) as compared to net cash used in operating activities of $(92,339) for the nine months ended March 31, 2023. The increase was primarily due to stock compensation of $324,523 in the 2024 period with no corresponding charge in the 2023 period, and increased accounts payable and accrued expenses in the 2024 period. We anticipate sustained or increased operational expenses as we transition our focus from product development to production and marketing efforts for the Smart Shin Guard, and as we continue to pursue new business through InSSIDe World Inc. as described above.

Cash Flows from Financing Activities:

Net cash provided by financing activities for the nine months ended March 31, 2024 were $88,367 compared to $92,672 for the nine months ended March 31, 2023, reflecting an increase in advances from related parties which partially offset a lack of issuances of common in the 2024 period when compared to the 2023 period.

Liquidity

We do not have sufficient available cash as of March 31, 2024 and for the past two years we have been relying on loans from our current investors and related parties and proceeds from sales of our common stock to fund our operations. As reflected in the financial statements contained in this Report, management has expressed substantial doubt about our ability to continue as a going concern for the next 12 months from the date the financial statements were issued, unless we can raise the required capital or generate material revenue to fund our operations.

The Company expects to continue to use a portion of the authorized but unissued shares to raise capital and/or to convert previous loans made to the Company.

The Company requires additional capital to continue its development efforts with respect to its products and services, which we may not be able to obtain on favorable terms, in the quantities and within the timeframes needed, or at all.

Cautionary Note Regarding Forward Looking Statements

This Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the development of the Smart Shin Guard and plans to begin commercializing the product, the development of InSSIDe World Inc. as a development-stage business with a focus on the clean energy and security sectors, the implementation of our business plan and expected timelines for meeting objectives, future sources of revenue such as a recent agreement with two of our subsidiaries and a third party consultant and customer, our use of common stock in capital raising efforts and to satisfy previous advances to us, and our liquidity. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods.

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements include the risks arising from the potential adverse effects of inflation, increasing interest rates in response, geopolitical conflicts such as those occurring in Israel and Ukraine and negative operational impacts or an economic downturn or recession which may result, which may result in declines in consumer spending particularly to non-essential products and services such as those that we intend to offer, global supply chain disruptions, shortages and delays which may adversely affect our ability to develop, manufacture and sell our products and services within the intended timeframes or at all, risks and uncertainties surrounding new business opportunities we pursue, and the risks summarized our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 in the section titled “Item 1A. – Risk Factors.” We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officers, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officers have concluded that our disclosure controls and procedures as of March 31, 2024 were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms because of a material weakness in the Company’s internal control over financial reporting. Specifically, the Company did not maintain effective controls to identify and maintain segregation of duties to support the identification, authorization, approval, accounting for, and the disclosure of related-party transactions and non-routine transactions. One individual, the Chief Executive Officer, initiates related-party transactions and non-routine transactions and also reviews, evaluates and approves these same transactions.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

From time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of the date of this Report, we are not aware of any other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

ITEM 1.A – RISK FACTORS

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

All unregistered sales of equity securities through the period covered by this Report have previously been disclosed.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5 - OTHER INFORMATION

During the three months ended March 31, 2024, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any “non-Rule 10b5-1 arrangement” as defined in Item 408(c) of Regulation S-K.

ITEM 6 – EXHIBITS

Incorporated by Reference

Filed or Furnished

Exhibit #

Exhibit Description

Form

Date

Number

Herewith

2.1

Certificate of Merger

10-K

2/18/2010

3.2

3.1

Amended and Restated Certificate of Incorporation

10-12G

3/9/2021

3.1

3.1(a)

Certificate of Amendment to Certificate of Incorporation (Reverse Stock Split)

10-Q

11/15/21

3.2

3.1(b)

Certificate of Amendment to Certificate of Incorporation (Decrease in Authorized Capital)

10-Q

11/15/2021

3.3

3.1(c)

Certificate of Designation

10-K

2/18/2010

3.3

3.2

Amended and Restated Bylaws

10-12G

3/9/2021

3.3

31.1

Certification of Principal Executive Officer (302)

Filed

31.2(a)

Certification of Principal Financial Officer (302)

Filed

31.2(b)

Certification of Principal Financial Officer (302)

Filed

32.1

Certification of Principal Executive and Principal Financial Officers (906)

Furnished*

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

Filed

101.SCH

Inline XBRL Taxonomy Extension Schema Document

Filed

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Filed

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

Filed

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

Filed

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

Filed

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Filed

*This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Copies of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to GHST World Inc., 667 Madison Avenue, 5th Floor, New York, NY 10065.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			GHST World Inc.
Dated:	May 10, 2024	By:		/s/ Edoardo Riboli
				Edoardo Riboli,Chief Executive Officer
				(Principal Executive Officer)
Dated:	May 10, 2024	By:		/s/ Marcello Appella
				Marcello Appella, Chief Financial Officer
				(Principal Financial Officer)
Dated:	May 10, 2024	By:		/s/ Paolo Sangiovanni
				Paolo Sangiovanni, Chief Financial Officer
				(Principal Financial Officer)

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Edoardo Riboli, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GHST World Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2024

/s/ Edoardo Riboli

Edoardo Riboli

Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2(a)

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Marcello Appella, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GHST World Inc.;

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2024

/s/ Marcello Appella

Marcello Appella

Chief Financial Officer

(Principal Financial Officer)

Exhibit 31.2(b)

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Paolo Sangiovanni, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GHST World Inc.;

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2024

/s/ Paolo Sangiovanni

Paolo Sangiovanni

Chief Financial Officer

(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of GHST World Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Edoardo Riboli, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edoardo Riboli

Edoardo Riboli

Chief Executive Officer

(Principal Executive Officer)

Dated: May 10, 2024

In connection with the quarterly report of GHST World, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Marcello Appella, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Marcello Appella

Marcello Appella

Chief Financial Officer

(Principal Financial Officer)

Dated: May 10, 2024

In connection with the quarterly report of GHST World, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Paolo Sangiovanni, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Paolo Sangiovanni

Paolo Sangiovanni

Chief Financial Officer

(Principal Financial Officer)

Dated: May 10, 2024

Cover - shares	9 Months Ended
Cover - shares	Mar. 31, 2024	May 07, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--06-30
Entity File Number	000-31705
Entity Registrant Name	GHST World Inc.
Entity Central Index Key	0001121795
Entity Tax Identification Number	91-2007477
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	667 Madison Avenue
Entity Address, Address Line Two	5th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10065
City Area Code	212
Local Phone Number	634-6860
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		130,201,179

Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current Assets
Cash	$ 76	$ 39,495
Accounts receivable	6,348	0
Total Current Assets	6,424	39,495
Total Assets	6,424	39,495
Current Liabilities
Accounts payable and accrued expenses	26,339	1,112
Advances from related parties	214,863	126,496
Common stock payable	9,559	9,559
Deferred revenue	17,367	23,841
Total Current Liabilities	268,128	161,008
Commitments and Contingencies (Note 6)
Stockholders’ Deficit
Common stock, $0.001 par value, 300,000,000 shares authorized; 130,201,179 shares issued at March 31, 2024 and June 30, 2023	130,201	125,725
Additional paid-in-capital	13,443,466	13,123,419
Accumulated deficit	(13,835,379)	(13,370,665)
Total Stockholders’ Deficit	(261,704)	(121,513)
Total Liabilities and Stockholders' Deficit	6,424	39,495
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock value	6	6
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock value	$ 2	$ 2

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	130,201,179	130,201,179
Series A Preferred Stock [Member]
Preferred stock, shares issued	6,000	6,000
Preferred stock, shares outstanding	6,000	6,000
Series B Preferred Stock [Member]
Preferred stock, shares issued	2,200	2,200
Preferred stock, shares outstanding	2,200	2,200

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 431	$ 0	$ 40,126	$ 0
Operating expenses:
General and administrative expenses	28,604	20,998	180,241	89,268
Product development costs	0	0	324,523	4,178
Total operating expenses	28,604	20,998	504,764	93,446
Other Income(expense):
Other income	258	0	(75)	0
Total Other Income (expense)	258	0	(75)	0
Net loss	$ (27,915)	$ (20,998)	$ (464,714)	$ (93,446)
Net loss per common share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Net loss per common share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding - basic	130,201,179	25,239,107	128,671,141	124,967,075
Weighted average number of common shares outstanding - diluted	130,201,179	25,239,107	128,671,141	124,967,075

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2022	$ 6	$ 2	$ 124,431	$ 13,028,646	$ (13,254,091)	$ (101,006)
Beginning balance, shares at Jun. 30, 2022	6,000	2,200	124,430,534
Issuance of common stock for services			$ 824	74,110		74,934
Issuance of common stock for cash, shares			824,869
Net loss					(93,446)	(93,446)
Ending balance, value at Mar. 31, 2023	$ 6	$ 2	$ 125,255	13,102,756	(13,347,537)	(119,518)
Ending balance, shares at Mar. 31, 2023	6,000	2,200	125,255,403
Beginning balance, value at Dec. 31, 2022	$ 6	$ 2	$ 125,222	13,100,789	(13,326,539)	(100,520)
Beginning balance, shares at Dec. 31, 2022	6,000	2,200	125,222,070
Issuance of common stock for services			$ 33	1,967		2,000
Issuance of common stock for cash, shares			33,333
Net loss					(20,998)	(20,998)
Ending balance, value at Mar. 31, 2023	$ 6	$ 2	$ 125,255	13,102,756	(13,347,537)	(119,518)
Ending balance, shares at Mar. 31, 2023	6,000	2,200	125,255,403
Beginning balance, value at Jun. 30, 2023	$ 6	$ 2	$ 125,725	13,123,419	(13,370,665)	(121,513)
Beginning balance, shares at Jun. 30, 2023	6,000	2,200	125,725,003
Issuance of common stock for services			$ 4,476	320,047		324,523
Issuance of common stock for cash, shares			4,476,176
Net loss					(464,714)	(464,714)
Ending balance, value at Mar. 31, 2024	$ 6	$ 2	$ 130,201	13,443,466	(13,835,379)	(261,704)
Ending balance, shares at Mar. 31, 2024	6,000	2,200	130,201,179
Beginning balance, value at Dec. 31, 2023	$ 6	$ 2	$ 130,201	13,443,466	(13,807,464)	(233,789)
Beginning balance, shares at Dec. 31, 2023	6,000	2,200	130,201,179
Net loss					(27,915)	(27,915)
Ending balance, value at Mar. 31, 2024	$ 6	$ 2	$ 130,201	$ 13,443,466	$ (13,835,379)	$ (261,704)
Ending balance, shares at Mar. 31, 2024	6,000	2,200	130,201,179

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (464,714)	$ (93,446)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock compensation	324,523	0
Changes in operating assets and liabilities:
Accounts receivable	(6,348)	0
Accounts payable and accrued expenses	25,227	1,108
Deferred revenue	(6,474)	0
Net Cash Used In Operating Activities	(127,786)	(92,339)
CASH FLOWS FROM FINANCING ACTIVITIES
Advances from related parties	88,367	17,737
Issuance of common stock for cash	0	74,935
Net Cash Provided By Financing Activities	88,367	92,672
Net increase (decrease) in cash	(39,419)	332
Cash - beginning of period	39,495	206
Cash - end of period	76	538
Cash paid during the year/period for:
Interest	0	0
Taxes	$ 0	$ 0

Pay vs Performance Disclosure - USD ($)	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ (27,915)	$ (20,998)	$ (464,714)	$ (93,446)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

9 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1- ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Background

Basis of Presentation

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Liquidity and Going Concern

Principles of Consolidation

The consolidated financial statements include the accounts of the following wholly owned subsidiaries:

GHST Art World, Inc

GHST Sport Inc.

IoTT world Inc.

Insside World Inc.

All intercompany balances and transactions have been eliminated in consolidation.

Concentration

Foreign Currency

Use of Estimates

Such estimates and assumptions impact, among others, the following: fair value of share-based payments and deferred taxes.

Cash

Cash are amounts held at local banks. The Company had no cash equivalents at March 31, 2024 or June 30, 2023.

Risks and Uncertainties

Revenue Recognition

Accounts Receivable

Fair Value

Level one — Quoted market prices in active markets for identical assets or liabilities.

Level two — Inputs other than level one inputs that are either directly or indirectly observable; and

Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Impairment of Long-Lived Assets

Research and Development

Research and development costs are expensed as incurred. These costs consist primarily of costs related to the development of new products.

Income Taxes

Stock Based Compensation

Net Loss Per Share

Recent Accounting Pronouncements

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

PATENTS

9 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

PATENTS

NOTE 3- PATENTS

COMMON STOCK PAYABLE

9 Months Ended

Mar. 31, 2024

Common Stock Payable

COMMON STOCK PAYABLE

NOTE 4- COMMON STOCK PAYABLE

RELATED PARTY TRANSACTIONS

9 Months Ended

Mar. 31, 2024

RELATED PARTY TRANSACTIONS

NOTE 5- RELATED PARTY TRANSACTIONS

STOCKHOLDERS’ EQUITY

9 Months Ended

Mar. 31, 2024

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 6- STOCKHOLDERS’ EQUITY

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 7- COMMITMENTS AND CONTINGENCIES

Legal Matters

IMPACT OF RESTATEMENT

9 Months Ended

Mar. 31, 2024

Accounting Changes and Error Corrections [Abstract]

IMPACT OF RESTATEMENT

NOTE 8- IMPACT OF RESTATEMENT


As of March 31, 2023
	As previously reported		Restatement Adjustment			As restated
Consolidated Balance Sheet
Patent costs	$	40,362	$	(40,362	)	$	—

For The Three Months Ended March 31, 2023
		As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	21,286		$	(288	)	$	20,998
Impairment of long-lived assets		—			—			—
Depreciation and Amortization		1,598			(1,598	)		—
Patent development costs		—			—			—
Net Loss	$	(22,884	)	$	(1,886	)	$	(20,998	)


For The Nine Months Ended March 31, 2023
	As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	89,449		$	(181	)	$	89,268
Impairment of long-lived assets		115,000			(115,000	)		—
Depreciation and Amortization		2,997			(2,997	)		—
Patent development costs		—			4,178			4,178
Net Loss	$	(207,446	)	$	(114,000	)	$	(93,446	)

Consolidated Statement of Changes in Stockholders’ Deficit
Accumulated deficit	$	(9,626,393	)	$	(3,721,144	)	$	(13,347,537	)
Total stockholders’ equity (deficit)	$	(64,815	)	$	(54,702	)	$	(119,518	)
Consolidated Statement of Cash Flow
Net cash used in operating activities	$	(88,339	)	$	(4,000	)	$	(92,339	)
Net cash provided by financing activities	$	92,850		$	(178	)	$	92,672
Net cash used in investing activities	$	(4,178	)	$	4,178		$	—

SUBSEQUENT EVENTS

9 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 9- SUBSEQUENT EVENTS

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Liquidity and Going Concern

Liquidity and Going Concern

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of the following wholly owned subsidiaries:

GHST Art World, Inc

GHST Sport Inc.

IoTT world Inc.

Insside World Inc.

All intercompany balances and transactions have been eliminated in consolidation.

Concentration

Concentration

Foreign Currency

Foreign Currency

Use of Estimates

Use of Estimates

Such estimates and assumptions impact, among others, the following: fair value of share-based payments and deferred taxes.

Cash

Cash

Cash are amounts held at local banks. The Company had no cash equivalents at March 31, 2024 or June 30, 2023.

Risks and Uncertainties

Risks and Uncertainties

Revenue Recognition

Revenue Recognition

Accounts Receivable

Accounts Receivable

Fair Value

Fair Value

Level one — Quoted market prices in active markets for identical assets or liabilities.

Level two — Inputs other than level one inputs that are either directly or indirectly observable; and

Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Research and Development

Research and Development

Research and development costs are expensed as incurred. These costs consist primarily of costs related to the development of new products.

Income Taxes

Income Taxes

Stock Based Compensation

Stock Based Compensation

Net Loss Per Share

Net Loss Per Share

Recent Accounting Pronouncements

Recent Accounting Pronouncements

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

IMPACT OF RESTATEMENT (Tables)

9 Months Ended

Mar. 31, 2024

Accounting Changes and Error Corrections [Abstract]

Schedule of reconciliation of the impacted consolidated financial statement


As of March 31, 2023
	As previously reported		Restatement Adjustment			As restated
Consolidated Balance Sheet
Patent costs	$	40,362	$	(40,362	)	$	—

For The Three Months Ended March 31, 2023
		As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	21,286		$	(288	)	$	20,998
Impairment of long-lived assets		—			—			—
Depreciation and Amortization		1,598			(1,598	)		—
Patent development costs		—			—			—
Net Loss	$	(22,884	)	$	(1,886	)	$	(20,998	)


For The Nine Months Ended March 31, 2023
	As previously reported			Restatement Adjustment			As restated
Consolidated Statement of Operations
General and administrative expenses	$	89,449		$	(181	)	$	89,268
Impairment of long-lived assets		115,000			(115,000	)		—
Depreciation and Amortization		2,997			(2,997	)		—
Patent development costs		—			4,178			4,178
Net Loss	$	(207,446	)	$	(114,000	)	$	(93,446	)

Consolidated Statement of Changes in Stockholders’ Deficit
Accumulated deficit	$	(9,626,393	)	$	(3,721,144	)	$	(13,347,537	)
Total stockholders’ equity (deficit)	$	(64,815	)	$	(54,702	)	$	(119,518	)
Consolidated Statement of Cash Flow
Net cash used in operating activities	$	(88,339	)	$	(4,000	)	$	(92,339	)
Net cash provided by financing activities	$	92,850		$	(178	)	$	92,672
Net cash used in investing activities	$	(4,178	)	$	4,178		$	—

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2022
Accounting Policies [Abstract]
Net losses	$ 27,915	$ 20,998	$ 464,714		$ 93,446
Accumulated deficit	13,835,379	13,347,537	13,835,379	$ 13,370,665	13,347,537
Stockholders' Deficit	261,704	$ 119,518	261,704	121,513	119,518	$ 233,789	$ 100,520	$ 101,006
Cash flow from operating activities			127,786		$ 92,339
Cash equivalents	0		0	0
Allowance for doubtful accounts	$ 0		0	0
Fair value of assets and liabilities measured on recurring basis			$ 0	$ 0
Potentially dilutive shares			0		0

PATENTS (Details Narrative) - Patents [Member] - USD ($)	9 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Accumulated costs			$ 39,181
Additional patent costs		$ 4,578
Total impairment			$ 39,181
Development costs	$ 0

COMMON STOCK PAYABLE (Details Narrative) - USD ($)	Sep. 30, 2021	Mar. 31, 2024	Jun. 30, 2023
Common Stock Payable
Reverse stock split	1-for-100
Common stock payable		$ 9,559	$ 9,559

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Related Party Transactions [Abstract]
Advances from related parties	$ 214,863	$ 126,496
Common stock payable - related parties	$ 9,559

STOCKHOLDERS’ EQUITY (Details Narrative) - Cross I N G A G [Member]		9 Months Ended
	Oct. 02, 2023 USD ($) shares	Mar. 31, 2024	Oct. 02, 2023 CHF (SFr) shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Agreement, nature and purpose		On September 22, 2023, the Company entered into an agreement with cross-ING AG, an artificial intelligence development entity in Switzerland. The joint venture was formed to create and deliver the software package tailored for GHST Sport Inc. The start of the project was October 2, 2023
Initial payments due	$ 45,272		SFr 40,000
Shares issued \| shares	4,476,176		4,476,176
Issuance of stock value \| $	$ 324,523
Royalties, description		Royalties will also be due under this agreement amounting to 1 CHF per unit sold up to 150,000 units.

IMPACT OF RESTATEMENT (Details) - USD ($)	3 Months Ended		9 Months Ended
IMPACT OF RESTATEMENT (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Patent costs		$ 0		$ 0
General and administrative expenses		20,998		89,268
Impairment of long-lived assets		0		0
Depreciation and Amortization		0		0
Patent development costs		0		4,178
Net loss	$ (27,915)	(20,998)	$ (464,714)	(93,446)
Accumulated deficit	(13,835,379)	(13,347,537)	(13,835,379)	(13,347,537)		$ (13,370,665)
Total stockholders' equity (deficit)	$ (261,704)	(119,518)	(261,704)	(119,518)	$ (233,789)	$ (121,513)	$ (100,520)	$ (101,006)
Net cash used in operating activities			(127,786)	(92,339)
Net cash provided by financing activities			$ 88,367	92,672
Net cash used in investing activities				0
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Patent costs		40,362		40,362
General and administrative expenses		21,286		89,449
Impairment of long-lived assets		0		115,000
Depreciation and Amortization		1,598		2,997
Patent development costs		0		0
Net loss		(22,884)		(207,446)
Accumulated deficit		(9,626,393)		(9,626,393)
Total stockholders' equity (deficit)		(64,815)		(64,815)
Net cash used in operating activities				(88,339)
Net cash provided by financing activities				92,850
Net cash used in investing activities				(4,178)
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Patent costs		(40,362)		(40,362)
General and administrative expenses		(288)		(181)
Impairment of long-lived assets		0		(115,000)
Depreciation and Amortization		(1,598)		(2,997)
Patent development costs		0		4,178
Net loss		(1,886)		(114,000)
Accumulated deficit		(3,721,144)		(3,721,144)
Total stockholders' equity (deficit)		$ (54,702)		(54,702)
Net cash used in operating activities				(4,000)
Net cash provided by financing activities				(178)
Net cash used in investing activities				$ 4,178

IMPACT OF RESTATEMENT (Details Narrative)	9 Months Ended
IMPACT OF RESTATEMENT (Details Narrative)	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Restatement and adjustments, description	The restatement and adjustments arising therefrom relates to the following corrections of errors contained in the previous financial statements for some or all of the Affected Periods: (i) the inclusion of a new non-cash expense arising from the issuance of approximately 118,663,761 shares of common stock during the fiscal year ended March 31, 2022 in satisfaction of indebtedness at an average price per share of approximately $0.00185, below the fair market value of the shares, (ii) a non-cash impairment related to the Company’s 119 art paintings, (iii) a non-cash write-off of patent costs, and (iv) a write-off of a related party receivable. As a result of these corrections, the Company’s net loss for the fiscal year ended March 31, 2022 increased from $151,885 as was reflected in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022 to approximately $3,987,000.